The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

Starting a GLP-1 drug was linked with a 14% overall reduced risk of new substance use disorders and a lower risk of harm for ...

A doctor sits with Tram Mai to discuss what we should know about GLP-1 drugs and their side effects. McDonald's CEO prepares ...

FDA sends Novo Nordisk 2nd warning over GLP-1 ads for misleading claims in Ozempic promotion and risk disclosure violations.

Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance ​use disorders and alleviate ...

GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, ...

GLP-1 drugs Ozempic, Wegovy, Mounjaro and Zepbound can help patients lose anywhere from 15% to 20% of body weight. But what ...